Hemodynamics of Leptomeningeal Collaterals after Large Vessel Occlusion and Blood Pressure Management with Endovascular Treatment

Article information

J Stroke. 2021;23(3):343-357

Publication date (electronic) : 2021 September 30

doi : https://doi.org/10.5853/jos.2021.02446

Beom Joon Kim^,^a

, Nishita Singh ^b, Bijoy K. Menon ^c

^aDepartment of Neurology and Cerebrovascular Center, Seoul National University Bundang Hospital, Seongnam, Korea

^bDepartment of Clinical Neurosciences, Foothills Medical Center, University of Calgary, Calgary, AB, Canada

Correspondence: Beom Joon Kim Department of Neurology and Cerebrovascular Center, Seoul National University Bundang Hospital, 82 Gumiro 173beon-gil, Bundang-gu, Seongnam 13620, Korea Tel: +82-31-787-7468 Fax: +82-31-787-4059 E-mail: Kim.BJ.Stroke@gmail.com

Received 2021 July 10; Revised 2021 September 3; Accepted 2021 September 9.

Abstract

Endovascular therapy (EVT) is an effective treatment for ischemic stroke due to large vessel occlusion (LVO). Unlike intravenous thrombolysis, EVT enables visualization of the restoration of blood flow, also known as successful reperfusion in real time. However, until successful reperfusion is achieved, the survival of the ischemic brain is mainly dependent on blood flow from the leptomeningeal collaterals (LMC). It plays a critical role in maintaining tissue perfusion after LVO via pre-existing channels between the arborizing pial small arteries or arterioles overlying the cerebral hemispheres. In the ischemic territory where the physiologic cerebral autoregulation is impaired and the pial arteries are maximally dilated within their capacity, the direction and amount of LMC perfusion rely on the systemic perfusion, which can be estimated by measuring blood pressure (BP). After the EVT procedure, treatment focuses on mitigating the risk of hemorrhagic transformation, potentially via BP reduction. Thus, BP management may be a key component of acute care for patients with LVO stroke. However, the guidelines on BP management during and after EVT are limited, mostly due to the scarcity of high-level evidence on this issue. In this review, we aim to summarize the anatomical and physiological characteristics of LMC to maintain cerebral perfusion after acute LVO, along with a landscape summary of the literature on BP management in endovascular treatment. The objective of this review is to describe the mechanistic association between systemic BP and collateral perfusion after LVO and thus provide clinical and research perspectives on this topic.

Keywords: Leptomeningeal collateral; Blood pressure; Large vessel occlusion; Cerebrovascular circulation; Endovascular recanalization; Ischemic stroke

Introduction

The efficacy of intravenous thrombolysis (IVT) and endovascular therapy (EVT) for acute ischemic stroke patients after large vessel occlusion (LVO) has been established by large randomized clinical trials [1]. However, approximately 50% of patients still experience functional dependency despite successful recanalization after timely treatment [1]. Variability in collateral perfusion before recanalization may be a potential reason for this [2].

The fate of brain cells in the ischemic region beyond the LVO depends on perfusion through the leptomeningeal collateral (LMC) overlying the cerebral hemisphere. Inadequate LMCs, either due to anatomical paucity or physiological dysfunction, lead to rapid infarct growth and may contribute to the progression of ischemia after LVO [3]. LMCs are an evolutionarily conserved anatomic structure but show substantial variability by species and individuals [4]. Left ventricular contraction determines the degree of systemic blood circulation; similarly, the direction and flow of LMC perfusion depends on hydrostatic pressure gradients between the arteriolar and venular ends of cerebral blood vessels [5]. After the loss of cerebral autoregulation (CA) in the region of severely depressed perfusion [6], cerebral blood flow (CBF) to the ischemic territory is predominantly a function of systemic perfusion pressure. Thus, systemic blood pressure (BP) may be regarded as an indirect measure of LMC perfusion. Modulation of LMC perfusion via systemic BP could therefore help maximize functional benefits during acute stroke care.

This article outlines how knowledge of the anatomy and physiology of LMCs may be applied clinically and provides an overview of current evidence on BP management during and after endovascular treatment, as well as its influence on treatment outcomes. In the absence of randomized controlled trial evidence, the purpose of this review is to help stroke physicians develop an anatomo-physiological model-based approach to BP management while caring for patients with LVO stroke.

Anatomy and physiology of leptomeningeal collaterals

Anatomy

In a normal physiological state, blood flows from the heart to the brain via the anterior circulation, which comprises the internal carotid artery, the middle cerebral artery (MCA), which supplies the majority of this circulation, and the anterior cerebral artery (ACA). Blood also flows via the posterior circulation, which is formed by the vertebral artery, basilar artery, and posterior cerebral artery (PCA). The average diameter of the MCA at its origin is approximately 4 mm, roughly twice that of the ACA, which is approximately 2 mm [7,8]. As the amount of blood flow roughly corresponds to the vascular diameter, the average CBF in the MCA (146±31 mL/min) usually exceeds the flow in the ACA (82±18 mL/min) [9].

On the surface of the cerebral hemisphere, the pial arteries lie within the subarachnoid space and provide perforating arteries into the brain parenchyma. The proximal part of the perforating arteries usually consists of an endothelium surrounded by a thick basement membrane material with embedded smooth muscle cells. However, at the capillary level, the vascular wall consists of a single layer of flattened endothelial cells with a very thin basement membrane and intermittent pericytes without smooth muscle cells [10]. The diameter of perforating arterioles varies by its function and location, and can range from 10 to 240 μm, with the largest one penetrating to the bottom of the sulci [11].

LMC channels consist of small precapillary arterial conduits of varying sizes lying between the pial arteries and arterioles in the cerebral cortex. There are two types of precapillary links: a larger one that connects the surface pial arteries in an end-to-end manner, and a smaller one that bridges smaller perforating arterioles often near the point of cortical penetration. The diameter of these anastomoses shows a wide range (10 to 30 μm) in their resting state [11]. These anastomotic channels work as the anatomical substrate of LMCs beyond an LVO.

Physiology

Perfusion through the arterial/arteriolar anastomoses described above is regulated by CA. CA is a normal physiological response that maintains constant blood flow in response to external and internal stimuli, such as changes in arterial BP between a mean arterial pressure (MAP) of 50 to 170 mm Hg [12,13]. CA provides adequate regional CBF in settings of decreased systemic perfusion or increased local metabolic demand after neuronal/cellular hyperactivity. CA is regulated by a complex interplay of myogenic, neurogenic, metabolic, and endothelial mechanisms [14], all of which modulate the diameter of cerebral vessels. Vascular smooth muscle cells at the precapillary level regulate the vascular diameter through nitric oxide from endothelial cells, neurogenic substances, and cellular metabolic by-products [15-17]. At the capillary level where smooth muscle cells are not found, the pericyte at the arteriolar side may contribute to vessel diameter modulation [18].

As CA depends on the regulation of arteriolar diameters, the functional capacity of CA is determined by the structural and functional properties of the pial artery and arteriolar anastomoses. The normal physiological response of vasodilation to decreased perfusion pressure is altered in various pathological conditions such as aging, long-standing hypertension, and hyperglycemia [19-21]. This resulting impairment in the CA response is not an all-or-none phenomenon but rather a graded and variable response (Figure 1) [22,23].

Figure 1.

Overview of leptomeningeal collaterals and cerebral autoregulation. (A) When a perfusion pressure gradient develops after large vessel occlusion, leptomeningeal collaterals are instantaneously recruited to provide cerebral perfusion to the ischemic territory within the functional capacity of cerebral autoregulation. (B) Microscopically, leptomeningeal collateral channels utilize pre-existing arterial tubular structures between the pial arteries, arterioles, or proximal branches. (C) The recruitment of leptomeningeal channels depends primarily on the myogenic dilatation of the pial arteries responsive to decreased local perfusion pressure (i.e., cerebral autoregulation).

Leptomeningeal collateral perfusion and systemic blood pressure after large vessel occlusion

After LVO, a significant drop in local perfusion pressure occurs within the affected vascular territory, resulting in a mismatch between metabolic demand and oxygen/nutritional supply. In response to this, LMCs are recruited by vasodilation of the pial arteries and arteriolar anastomoses to their maximum available capacity. The average diameter of these anastomoses is less than 10 to 20 μm in the resting state, but when fully recruited after LVO, their diameter increases almost 6-fold (60 to 120 μm) [24]. Experimental animal model data have shown that this recruitment occurs almost instantaneously after LVO and takes an average of 12 seconds to reach a maximum [25]. As the direction of blood flow through the LMC channel is determined by the perfusion pressure gradient at both ends of the conduit [26], the collateral perfusion passively flows from the ACA or PCA to the ischemic territory in the case of MCA occlusion.

Before successful recanalization is achieved after LVO, the objective of medical management is to prevent irreversible infarction of the ischemic penumbra. Cerebral autoregulatory mechanisms are unable to provide adequate regional CBF due to the severely depressed level of perfusion pressure [27], with the cardiac output now becoming the sole driving force of regional CBF. Informed by this physiological model, stroke physicians do not intentionally lower BP in acute ischemic stroke patients unless it is extremely high [28,29]. However, this simple physiological model does not fully consider the complex interplay between any remaining CA capacity, extent and amount of LMC perfusion, and systemic BP [30]. In this sense, early infarct growth will be a function of time from onset, ischemic severity, that is, baseline LMC perfusion, and tissue vulnerability [31,32].

After successful recanalization, the objective of BP management should be to mitigate the risk of hemorrhagic transformation. The prevailing belief is that lowering BP may prevent hemorrhagic transformation after EVT. However, this simple model does not consider the fact that angiographic recanalization does not always guarantee tissue reperfusion. Examples of such physiology include the “no-reflow” phenomenon and partial recanalization [33,34], situations in which patients may benefit from relatively higher local perfusion pressure [35].

Levels and variabilities of blood pressure in peri-endovascular treatment and stroke outcomes

In the early EVT era, studies mainly focused on one parameter for BP management: BP at the time of hospital arrival (Table 1) [36-42]. Both extremely high and low values of BP on arrival were associated with poor functional recovery or hemorrhagic transformation after EVT [36-38]. The largest dataset to date on this topic was from the Multicenter Randomized Clinical Trial of Endovascular Treatment of Acute Ischemic Stroke in the Netherlands (MR CLEAN) registry with 3,180 EVT cases, which showed a J-shaped association between BP on admission and mortality or functional recovery and an inflection point at 150/81 mm Hg [39]. However, BP at presentation is not modifiable.

Table 1.

Admission BP and EVT outcomes

The effect of procedural BP during EVT is mostly analyzed in conjunction with the type of anesthesia; therefore, the BP profile in such reports cannot be entirely distinguished from its influence (Table 2) [40,43-61]. It is not uncommon during general anesthesia (GA) to have hypotensive episodes due to anesthesia drugs, intravascular hypovolemia, high intrathoracic pressures, and impaired sympathetic tone [62]. GA is usually correlated with lower BP levels and unfavorable outcomes compared to local anesthesia or conscious sedation [43,44]. The Sedation vs. Intubation for Endovascular Stroke Treatment (SIESTA) and General or Local Anesthesia in Intra-arterial Therapy (GOLIATH) trials were conducted to investigate the association between anesthesia and EVT outcomes [63,64]. Post hoc analyses of these trials reported that stroke outcomes were not associated with the magnitude of BP reduction and type of anesthesia [40,45]. However, subsequent analyses showed that the degree of systolic blood pressure (SBP) or MAP reduction correlated with the volume of infarction and with clinical deficits [46-48]. When individual patient data were combined, longer cumulative durations of MAP less than 70 mm Hg or greater than 90 mm Hg were related to poor functional outcomes [49]. Likewise, data from the MR CLEAN registry showed that a combination of prolonged duration of BP reduction with lower BP level was associated with worse 3-month outcomes [50].

Table 2.

BP during the EVT procedure and outcomes

BP measurements obtained after EVT received more attention only after the effectiveness of EVT was proven in clinical trials (Table 3) [40,65-95]. Studies have shown that higher BP after EVT correlates with a higher risk of hemorrhagic transformation, poor functional recovery, and mortality [65-69,96]. The Blood Pressure after Endovascular Therapy for Ischemic Stroke (BEST) study, a multicenter study of 485 EVT cases collected from 12 comprehensive stroke centers, documented that peak SBP <158 mm Hg 24 hours post-EVT was associated with an increased probability of good functional outcomes [70].

Table 3.

Post-procedural BP and the recanalization treatment outcomes

Due to the relatively regular interval of BP measurements during the post-EVT phase, the effect of BP variability post-EVT has also been investigated well, with multiple studies showing that higher BP variability is associated with larger infarct volume and poor functional recovery [71,97]. In a secondary analysis of the BEST study, it was shown that the correlation between BP levels and poor functional outcomes became more robust in the group with high BP variability, which suggests an additive effect of BP variability over absolute BP levels [72]. One shortcoming of such analyses is the neglect of the time gap between BP measurements when measuring BP variability. To address this issue, the concept of the rate of BP change, that is, mm Hg/min, was proposed. This rate of change in BP was associated with an increased risk of symptomatic hemorrhage after EVT in one study [73]. Spontaneous reduction of BP after recanalization is well known [98]. In the post-EVT phase, some studies have noted poor outcomes with less BP reduction in those who had relatively higher BP compared to the baseline [70,74]. Current analyses of BP variability, however, continue to be limited. Future analyses may need to incorporate longer-term trajectories and the rapidity of changes in BP readings during the hyperacute period.

Summary of current evidence for clinical practice

Current clinical guidelines and summary of the literature on BP management during the peri-endovascular treatment period

The BP management recommendations from current guidelines may be summarized as follows [28,29]:

(1) Routine use of BP-lowering medication before recanalization treatment (thrombolysis and/or EVT) is not well established and is not recommended unless >220/110 mm Hg.

(2) For IVT alone, it is recommended to maintain a BP <185/110 mm Hg before, during, and 24 hours after treatment.

(3) For EVT, intensive BP lowering in the peri-EVT period lacks clear benefits. It is suggested that BP be maintained at <185/105 mm Hg during and after the procedure. This recommendation was based on recent clinical trial protocols.

The landscape review from the previous section can be summarized as follows:

(1) Admission BP has a J- or U-shaped association with clinical outcomes after EVT.

(2) Prolonged duration of low BP during EVT procedures is associated with unfavorable outcomes.

(3) BP variability after EVT correlates with a higher risk of poor functional recovery and/or increased rates of hemorrhagic complications.

(4) Relatively lower BP reductions after EVT are associated with poor functional recovery.

A tentative suggestion for the BP management of patients with EVT

Pre-EVT period

The objective of BP management during this period should be to maximize the viability of the ischemic penumbra. The recent literature is inconclusive, with both higher or lower levels of admission BPs reported to be correlated with poor outcomes. Current guidelines recommend that EVT candidates maintain an SBP <185 mm Hg. This BP threshold is a legacy from the eligibility criteria for the intravenous thrombolysis trial [99]. Although this threshold BP level was not validated in any of the EVT trials, there is currently no evidence to suggest any other threshold level in these patients. Likewise, there is still minimal evidence to support increased cerebral perfusion after an LVO stroke after iatrogenically induced hypertension. Thus, it is advisable to maintain the BP level that the patient presents before the initiation of EVT.

Procedural BP

Most studies investigating procedural BP levels reported a higher likelihood of poor outcomes after a prolonged duration of lower or higher BP. However, these two points require further discussion. First, these were post hoc analyses of studies that compared the route of anesthesia. Thus, the deleterious effect of low BP cannot be separated from that of anesthetics [48-50]. Second, collateral perfusion through the LMC mainly works before recanalization. The collateral perfusion will instantaneously reverse back to physiological status as soon as the orthotropic flow is restored [5]. Therefore, the procedural BP management strategy may need to distinguish whether recanalization is achieved.

Before recanalization, as in the pre-EVT period, the objective of BP management should be to ensure the viability of the ischemic penumbra. Prolonged exposure to low or high BP should be avoided. A mean arterial BP range between 70 and 90 mm Hg was suggested by one study [49]. After recanalization, the BP management strategy would follow that for the post-recanalization period.

Post-recanalization period

The primary goal of BP management after successful recanalization is to mitigate the risk of hemorrhagic complications and stabilize ischemic tissues. Randomized clinical trials to test the efficacy of EVT for anterior circulation LVO have specified some BP management instructions. The Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE) trial recommended SBP values ≥150 mm Hg while the artery remains occluded; controlling BP once reperfusion has been achieved while aiming for a normal BP in an individual is sensible [100]. A recent EVT trial proposed SBP <140 mm Hg after successful EVT [101]. In general, higher BP levels during the acute period tend to stabilize after recanalization treatment [98]. Post hoc analyses of the BEST study and the Safe Implementation of Thrombolysis in Stroke International Stroke Thrombolysis Registry (SITS-ISTR) identified that higher BP after EVT is associated with poor outcomes [72,74]. Further studies and discussion should be conducted to investigate whether the unfavorable effect of higher-than-usual BP is reproduced consistently over the recanalization grades, that is, cases with post-EVT recanalization grades modified treatment in cerebral ischemia (mTICI) 2b, 2c, and 3. A patient who had mTICI of 2b recanalization but with occlusion of a distal branch supplying the precentral gyrus may benefit from higher BP levels to support local LMC perfusion. Additionally, the association between BP variability and poor treatment outcomes has been consistently reported in the post-EVT period. Lastly, there is limited evidence that higher BP levels after recanalization cause hemorrhagic transformation.

Thus, the following rule of thumb may be considered until more evidence emerges.

(1) In the post-recanalization period, it is best to maintain the BP level of the patient.

(2) The practice of lowering SBP to less than 140 mm Hg after successful recanalization is not based on proven evidence.

(3) We suggest monitoring BP levels after recanalization and treating only if BP levels are very high; for example, >185 mm Hg systolic when IVT has already been offered or when recanalization grade mTICI 2c or 3 has been achieved.

(4) Higher BP levels after recanalization may portend unfavorable treatment outcomes.

Research perspective

Despite a large body of literature, current clinical guidelines provide limited recommendations regarding BP management strategies in the peri-EVT period. One obvious reason is the retrospective and observational design of published studies. However, BP can be easily measured and readily controlled by parenteral medications. Owing to constant fluctuation in BP during this period, clinical inertia, that is, ignoring outlier BP values, may creep unintentionally. The discrepancy between a prespecified BP target and achieved BP levels is not infrequent in real-world clinical practice. In a recent clinical trial, the BP-Blood Pressure target in Acute Stroke to Reduce Hemorrhage after Endovascular Therapy (TARGET) study randomized 324 cases into an intensive SBP target (100 to 129 mm Hg) and a standard SBP target (130 to 185 mm Hg) during the 24 hours after EVT. The two groups were comparable in radiographic intraparenchymal hemorrhage at 24 to 36 hours, as well as functional recovery and safety outcomes. However, there was an unintended crossover between the assigned target group; patients in the intensive arm spent approximately a third of the duration in the SBP target range of the control arm [75]. Such crossover was also noted in a prospective cohort from eight comprehensive stroke centers that grouped EVT patients into intensive (<140 mm Hg), moderate (<160 mm Hg), and usual (<180 mm Hg) SBP management groups [76]. Despite significant benefits from the moderate target compared to the guideline-recommended target group, the mean SBP levels were almost identical in both groups. Studies focusing on prespecified SBP targeting after EVT need to consider the stabilizing trends of BP after treatment and the inadvertent effect of treating physicians’ behavior and preconceptions.

Summary measures for BP

Repeated measures of BP over time were obtained from a single patient. However, in clinical practice, these measurements are recorded over various time intervals, thus providing only a screenshot of the dynamic readings in time. Considering that every cardiac beat generates SBP and diastolic BP (Figure 2A), the recorded BP values represent only a fraction of the potentially available BP data. Therefore, to capture maximum information, researchers need to carefully choose indices such as BP level, BP variability, and BP trajectory (Figure 2).

Figure 2.

Characteristics of blood pressure measurements and summary indices. Systolic and diastolic blood pressure (BP) is determined during every cardiac cycle. Intermittent measurements in routine clinical practice may capture only a fraction of the available BP measurements. BP measurements can be obtained repeatedly and exhibit constant fluctuations (A). The measurement density of BPs may be different throughout acute in-hospital care, that is, pre-endovascular treatment (EVT), during the procedure, as well as post-EVT. BP measurements can be summarized using means, as highlighted by the yellow line in the figure. The average BP level is intuitive and easy to calculate, but it does not reflect the variability and fluctuations in BP measurements that occur in a patient (B). Fluctuations of BP can be described by various variability measures, including standard deviations, coefficient of variations, maximum decrements, and average real variability, to name a few. In general, variability measures are calculated by taking the differences between each measurement or the differences between specific values (yellow lines). However, such variability measures do not provide information on the time intervals of the measurements. Thus, the absolute BP variability values may decrease during high measurement density periods such as during EVT procedures (C). The trajectory group describes the overall path (yellow line) of BP measurements over a certain period of time. By using a mixture model, clusters of patients with similar patterns of BP measurements over a period of time may be identified and grouped [104]. Five groups of acute BP trajectories were identified from a clinical registry of 8,000 stroke cases [103]. Trajectory groups are easy to recognize in clinical practice even before the measurement period is completed. However, the trajectory group estimation process depends on the characteristics of the source data and the modeling specification, and thus, the generalizability of the model is limited (D). IV, intravenous.

BP level, usually presented as mean BP over a specific duration, expresses the status of BP at a particular time point or period. This level is intuitive to physicians, and the change in the BP level may provide practical information (Figure 2B) [74]. However, this measure does not capture information about the BP variation generated by every cardiac beat. Variability is a summary measure of the fluctuation of the measurements over a specific duration (Figure 2C). It is not easy to set up a specific threshold of BP variability that warrants clinical intervention, as accurately measuring variability requires a sufficient count of BP measurements to be calculated. It should also be acknowledged that variability indices are affected by the temporal density of BP measurements and BP levels. The absolute BP variability value may decrease during a high measurement density period, that is, during the EVT procedure. Short-term variability is also affected by physical activity, emotional stress, and circadian rhythm, all of which augment the complexity of interpretation of such data [102]. BP trajectories focus on identifying a specific group following a similar trend and pattern of the BP measurements over a certain period (Figure 2D) [103,104]. Trajectory grouping and estimation procedures currently require specific model specifications and are not widely applied to the acute stroke period.

The relationship between leptomeningeal collaterals and blood pressure in patients with large vessel occlusions

As discussed in this review, regional tissue perfusion after LVO is maintained by the LMC channels. The recruitment of these LMC channels is determined by the pressure gradient between the arterial blood flow generated by cardiac contraction and venous blood flow. Based on this simple and linear model, it is intuitive to suppose that cerebral tissue perfusion after LVO may be regulated through systemic BP management.

However, the small arteries and arterioles of the brain have CA capacity, which modulates the vascular diameter to maintain almost constant CBF in response to local perfusion pressure changes. Therefore, the brain tissue that may receive increased local CBF from augmenting systemic BP is likely to be either the ischemic core or the ischemic penumbra without autoregulatory function. A long history of hypertension may indicate impaired autoregulatory function [105]. Additionally, as the blood flow inversely corresponds to the fourth-order of the vascular luminal diameter, the LMC perfusion will not suffice to replace the normal physiologic CBF through anatomically intact large vessels.

Based on the above, the following can be stated:

(1) The effect of systemic BP on blood flow distal to an LVO may vary based on the anatomic extent of the LMC channels and the remaining autoregulatory function.

(2) Ischemic brain injury may affect the vascular endothelium, pericytes, glia, and neuronal cells, and it prevents the maintenance of normal autoregulatory function. The autoregulatory function may also be affected by prior conditions, such as hypertension and diabetes mellitus.

(3) In general, LMC perfusion only provides inadequate blood flow that cannot sustain brain tissue viability for long.

(4) The BP management strategy for acute ischemic stroke patients may need to be personalized based on the individual assessment of the LMC channels and autoregulatory capacity.

Whether baseline hemodynamic status modifies the association between BP profiles and ischemic or functional outcomes is a fascinating research topic [106]. This issue has recently gained interest with studies showing that poor baseline collaterals can aggravate the deleterious effects of higher BP levels or higher BP variability on clinical outcomes [51,77]. The association between BP and stroke outcomes may also differ by baseline perfusion status, that is, the extent and grade of LMC and tissue perfusion. As discussed in the previous section, early infarct growth may be a function of time from onset, ischemic severity (i.e., baseline LMC perfusion), and tissue vulnerability [31,32]. It can be speculated that in patients with poor LMCs after LVO, ischemic injury rapidly develops, and the only effective treatment strategy is to expedite recanalization. In contrast, in the presence of moderate LMCs, tissue viability mainly depends on systemic perfusion, and clinicians should be sensitive to even minute changes in BP. Meanwhile, in patients with excellent or good collaterals, one can expect a higher tolerance to modest BP fluctuations. This conjecture needs to be validated in future studies.

Conclusions

In current practice, stroke physicians use BP measurements as a proxy for brain perfusion pressure. Conceptually, the objective of BP management in the pre-recanalization phase is to maintain sufficient LMC perfusion. In the post-recanalization phase, the objective is to prevent hemorrhagic complications and stabilize the ischemic brain tissues. At present, the available research on BP management in EVT shows that higher BP on admission, lower BP levels post-recanalization, higher BP variability or variable trajectories, and prolonged durations of low BP during EVT are all associated with poor functional outcomes. However, the optimal BP level, variability, and trajectory for each phase are yet to be determined. Based on current anatomical and physiological knowledge, the ultimate goal is to directly gauge the amount and capacity of LMC perfusion after LVO to provide maximally available CBF to the ischemic brain until successful recanalization is achieved and to mitigate undesirable complications subsequent to ischemia and reperfusion. Given the heterogeneity of the anatomy and variability of the physiology of the LMC, understanding its behavior during stroke is now more pressing than ever. It is paramount that more novel mechanisms and parameters to assess regional brain perfusion and functioning CA capacity at the bedside are developed in order to individualize BP management in the periEVT period [52,78].

Notes

Disclosure

The authors have no financial conflicts of interest.

References

1. Goyal M, Menon BK, van Zwam WH, Dippel DW, Mitchell PJ, Demchuk AM, et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet 2016;387:1723–1731.

2. Yu I, Bang OY, Chung JW, Kim YC, Choi EH, Seo WK, et al. Admission diffusion-weighted imaging lesion volume in patients with large vessel occlusion stroke and Alberta Stroke Program Early CT Score of ≥6 points: serial computed tomography-magnetic resonance imaging collateral measurements. Stroke 2019;50:3115–3120.

3. Albers GW. Late window paradox. Stroke 2018;49:768–771.

4. Winship IR. Cerebral collaterals and collateral therapeutics for acute ischemic stroke. Microcirculation 2015;22:228–236.

5. Brozici M, van der Zwan A, Hillen B. Anatomy and functionality of leptomeningeal anastomoses: a review. Stroke 2003;34:2750–2762.

6. Cipolla MJ, McCall AL, Lessov N, Porter JM. Reperfusion decreases myogenic reactivity and alters middle cerebral artery function after focal cerebral ischemia in rats. Stroke 1997;28:176–180.

7. Gibo H, Carver CC, Rhoton AL Jr, Lenkey C, Mitchell RJ. Microsurgical anatomy of the middle cerebral artery. J Neurosurg 1981;54:151–169.

8. Gomes FB, Dujovny M, Umansky F, Berman SK, Diaz FG, Ausman JI, et al. Microanatomy of the anterior cerebral artery. Surg Neurol 1986;26:129–141.

9. Zarrinkoob L, Ambarki K, Wåhlin A, Birgander R, Eklund A, Malm J. Blood flow distribution in cerebral arteries. J Cereb Blood Flow Metab 2015;35:648–654.

10. Jones EG. On the mode of entry of blood vessels into the cerebral cortex. J Anat 1970;106(Pt 3):507–520.

11. Duvernoy HM, Delon S, Vannson JL. Cortical blood vessels of the human brain. Brain Res Bull 1981;7:519–579.

12. Kennedy McConnell F, Payne S. The dual role of cerebral autoregulation and collateral flow in the circle of willis after major vessel occlusion. IEEE Trans Biomed Eng 2017;64:1793–1802.

13. Aaslid R, Lindegaard KF, Sorteberg W, Nornes H. Cerebral autoregulation dynamics in humans. Stroke 1989;20:45–52.

14. Ainslie PN, Duffin J. Integration of cerebrovascular CO2 reactivity and chemoreflex control of breathing: mechanisms of regulation, measurement, and interpretation. Am J Physiol Regul Integr Comp Physiol 2009;296:R1473–R1495.

15. Peterson EC, Wang Z, Britz G. Regulation of cerebral blood flow. Int J Vasc Med 2011;2011:823525.

16. Asgari S, Bergsneider M, Hamilton R, Vespa P, Hu X. Consistent changes in intracranial pressure waveform morphology induced by acute hypercapnic cerebral vasodilatation. Neurocrit Care 2011;15:55–62.

17. Witthoft A, Em Karniadakis G. A bidirectional model for communication in the neurovascular unit. J Theor Biol 2012;311:80–93.

18. Attwell D, Mishra A, Hall CN, O’Farrell FM, Dalkara T. What is a pericyte? J Cereb Blood Flow Metab 2016;36:451–455.

19. Ma J, Ma Y, Shuaib A, Winship IR. Impaired collateral flow in pial arterioles of aged rats during ischemic stroke. Transl Stroke Res 2020;11:243–253.

20. Chan SL, Sweet JG, Bishop N, Cipolla MJ. Pial collateral reactivity during hypertension and aging: understanding the function of collaterals for stroke therapy. Stroke 2016;47:1618–1625.

21. Biose IJ, Dewar D, Macrae IM, McCabe C. Impact of stroke co-morbidities on cortical collateral flow following ischaemic stroke. J Cereb Blood Flow Metab 2020;40:978–990.

22. Castro P, Azevedo E, Sorond F. Cerebral autoregulation in stroke. Curr Atheroscler Rep 2018;20:37.

23. Hecht N, Schrammel M, Neumann K, Müller MM, Dreier JP, Vajkoczy P, et al. Perfusion-dependent cerebral autoregulation impairment in hemispheric stroke. Ann Neurol 2021;89:358–368.

24. Coyle P. Diameter and length changes in cerebral collaterals after middle cerebral artery occlusion in the young rat. Anat Rec 1984;210:357–364.

25. Morita Y, Fukuuchi Y, Koto A, Suzuki N, Isozumi K, Gotoh J, et al. Rapid changes in pial arterial diameter and cerebral blood flow caused by ipsilateral carotid artery occlusion in rats. Keio J Med 1997;46:120–127.

26. Rocha M, Jovin TG. Fast versus slow progressors of infarct growth in large vessel occlusion stroke: clinical and research implications. Stroke 2017;48:2621–2627.

27. Dirnagl U, Pulsinelli W. Autoregulation of cerebral blood flow in experimental focal brain ischemia. J Cereb Blood Flow Metab 1990;10:327–336.

28. Sandset EC, Anderson CS, Bath PM, Christensen H, Fischer U, Gąsecki D, et al. European Stroke Organisation (ESO) guidelines on blood pressure management in acute ischaemic stroke and intracerebral haemorrhage. Eur Stroke J 2021;6:48–89.

29. Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2019;50:e344–e418.

30. Jeong HG, Kim BJ, Kim H, Jung C, Han MK, Liebeskind DS, et al. Blood pressure drop and penumbral tissue loss in nonrecanalized emergent large vessel occlusion. Stroke 2019;50:2677–2684.

31. Puhr-Westerheide D, Tiedt S, Rotkopf LT, Herzberg M, Reidler P, Fabritius MP, et al. Clinical and imaging parameters associated with hyperacute infarction growth in large vessel occlusion stroke. Stroke 2019;50:2799–2804.

32. Broocks G, Rajput F, Hanning U, Faizy TD, Leischner H, Schön G, et al. Highest lesion growth rates in patients with hyperacute stroke. Stroke 2019;50:189–192.

33. El Amki M, Glück C, Binder N, Middleham W, Wyss MT, Weiss T, et al. Neutrophils obstructing brain capillaries are a major cause of no-reflow in ischemic stroke. Cell Rep 2020;33:108260.

34. Liebeskind DS, Bracard S, Guillemin F, Jahan R, Jovin TG, Majoie CB, et al. eTICI reperfusion: defining success in endovascular stroke therapy. J Neurointerv Surg 2019;11:433–438.

35. Mistry EA, Mayer SA, Khatri P. Blood pressure management after mechanical thrombectomy for acute ischemic stroke: a survey of the StrokeNet sites. J Stroke Cerebrovasc Dis 2018;27:2474–2478.

36. Nogueira RG, Liebeskind DS, Sung G, Duckwiler G, Smith WS; MERCI, et al. Predictors of good clinical outcomes, mortality, and successful revascularization in patients with acute ischemic stroke undergoing thrombectomy: pooled analysis of the Mechanical Embolus Removal in Cerebral Ischemia (MERCI) and Multi MERCI Trials. Stroke 2009;40:3777–3783.

37. Mulder MJ, Ergezen S, Lingsma HF, Berkhemer OA, Fransen PS, Beumer D, et al. Baseline blood pressure effect on the benefit and safety of intra-arterial treatment in MR CLEAN (Multicenter Randomized Clinical Trial of Endovascular Treatment of Acute Ischemic Stroke in the Netherlands). Stroke 2017;48:1869–1876.

38. Maïer B, Gory B, Taylor G, Labreuche J, Blanc R, Obadia M, et al. Mortality and disability according to baseline blood pressure in acute ischemic stroke patients treated by thrombectomy: a collaborative pooled analysis. J Am Heart Assoc 2017;6:e006484.

39. Van den Berg SA, Uniken Venema SM, Mulder MJ, Treurniet KM, Samuels N, Lingsma HF, et al. Admission blood pressure in relation to clinical outcomes and successful reperfusion after endovascular stroke treatment. Stroke 2020;51:3205–3214.

40. Schönenberger S, Uhlmann L, Ungerer M, Pfaff J, Nagel S, Klose C, et al. Association of blood pressure with short- and long-term functional outcome after stroke thrombectomy: post hoc analysis of the SIESTA trial. Stroke 2018;49:1451–1456.

41. Goyal N, Tsivgoulis G, Iftikhar S, Khorchid Y, Fawad Ishfaq M, Doss VT, et al. Admission systolic blood pressure and outcomes in large vessel occlusion strokes treated with endovascular treatment. J Neurointerv Surg 2017;9:451–454.

42. Anadani M, Lapergue B, Blanc R, Kyheng M, Labreuche J, Machaa MB, et al. Admission blood pressure and outcome of endovascular therapy: secondary analysis of ASTER trial. J Stroke Cerebrovasc Dis 2020;29:105347.

43. Davis MJ, Menon BK, Baghirzada LB, Campos-Herrera CR, Goyal M, Hill MD, et al. Anesthetic management and outcome in patients during endovascular therapy for acute stroke. Anesthesiology 2012;116:396–405.

44. Jagani M, Brinjikji W, Rabinstein AA, Pasternak JJ, Kallmes DF. Hemodynamics during anesthesia for intra-arterial therapy of acute ischemic stroke. J Neurointerv Surg 2016;8:883–888.

45. Rasmussen M, Espelund US, Juul N, Yoo AJ, Sørensen LH, Sørensen KE, et al. The influence of blood pressure management on neurological outcome in endovascular therapy for acute ischaemic stroke. Br J Anaesth 2018;120:1287–1294.

46. Pikija S, Trkulja V, Ramesmayer C, Mutzenbach JS, Killer-Oberpfalzer M, Hecker C, et al. Higher blood pressure during endovascular thrombectomy in anterior circulation stroke is associated with better outcomes. J Stroke 2018;20:373–384.

47. Petersen NH, Ortega-Gutierrez S, Wang A, Lopez GV, Strander S, Kodali S, et al. Decreases in blood pressure during thrombectomy are associated with larger infarct volumes and worse functional outcome. Stroke 2019;50:1797–1804.

48. Valent A, Sajadhoussen A, Maier B, Lapergue B, Labeyrie MA, Reiner P, et al. A 10% blood pressure drop from baseline during mechanical thrombectomy for stroke is strongly associated with worse neurological outcomes. J Neurointerv Surg 2020;12:363–369.

49. Rasmussen M, Schönenberger S, Hendèn PL, Valentin JB, Espelund US, Sørensen LH, et al. Blood pressure thresholds and neurologic outcomes after endovascular therapy for acute ischemic stroke: an analysis of individual patient data from 3 randomized clinical trials. JAMA Neurol 2020;77:622–631.

50. Samuels N, van de Graaf RA, van den Berg CAL, Nieboer D, Eralp I, Treurniet KM, et al. Blood pressure during endovascular treatment under conscious sedation or local anesthesia. Neurology 2021;96:e171–e181.

51. Maïer B, Dargazanli C, Bourcier R, Kyheng M, Labreuche J, Mosimann PJ, et al. Effect of steady and dynamic blood pressure parameters during thrombectomy according to the collateral status. Stroke 2020;51:1199–1206.

52. Petersen NH, Silverman A, Strander SM, Kodali S, Wang A, Sansing LH, et al. Fixed compared with autoregulation-oriented blood pressure thresholds after mechanical thrombectomy for ischemic stroke. Stroke 2020;51:914–921.

53. Löwhagen Hendén P, Rentzos A, Karlsson JE, Rosengren L, Sundeman H, Reinsfelt B, et al. Hypotension during endovascular treatment of ischemic stroke is a risk factor for poor neurological outcome. Stroke 2015;46:2678–2680.

54. John S, Hazaa W, Uchino K, Toth G, Bain M, Thebo U, et al. Lower intraprocedural systolic blood pressure predicts good outcome in patients undergoing endovascular therapy for acute ischemic stroke. Interv Neurol 2016;4:151–157.

55. Whalin MK, Halenda KM, Haussen DC, Rebello LC, Frankel MR, Gershon RY, et al. Even small decreases in blood pressure during conscious sedation affect clinical outcome after stroke thrombectomy: an analysis of hemodynamic thresholds. AJNR Am J Neuroradiol 2017;38:294–298.

56. Athiraman U, Sultan-Qurraie A, Nair B, Tirschwell DL, Ghodke B, Havenon AD, et al. Endovascular treatment of acute ischemic stroke under general anesthesia: predictors of good outcome. J Neurosurg Anesthesiol 2018;30:223–230.

57. Treurniet KM, Berkhemer OA, Immink RV, Lingsma HF, Wardvan der Stam VM, Hollmann MW, et al. A decrease in blood pressure is associated with unfavorable outcome in patients undergoing thrombectomy under general anesthesia. J Neurointerv Surg 2018;10:107–111.

58. Pikija S, Millesi K, Killer-Oberpfalzer M, Mutzenbach JS, Sztriha LK, Füssel MU, et al. Blood pressure characteristics in patients with acute basilar artery occlusion undergoing endovascular thrombectomy. Sci Rep 2019;9:13224.

59. Fandler-Höfler S, Heschl S, Argüelles-Delgado P, Kneihsl M, Hassler E, Magyar M, et al. Single mean arterial blood pressure drops during stroke thrombectomy under general anaesthesia are associated with poor outcome. J Neurol 2020;267:1331–1339.

60. Xu C, Lin G, Zhang Z, Jin T, Li N, Mao H, et al. Prolonged duration of blood pressure drops during general anesthesia is associated with worse outcomes after mechanical thrombectomy. Front Neurol 2021;12:640841.

61. Chen M, Kronsteiner D, Pfaff J, Schieber S, Jäger L, Bendszus M, et al. Hemodynamic status during endovascular stroke treatment: association of blood pressure with functional outcome. Neurocrit Care 2021 Jun 17 [Epub]. https://doi.org/10.1007/s12028-021-01229-w.

62. Südfeld S, Brechnitz S, Wagner JY, Reese PC, Pinnschmidt HO, Reuter DA, et al. Post-induction hypotension and early intraoperative hypotension associated with general anaesthesia. Br J Anaesth 2017;119:57–64.

63. Schönenberger S, Uhlmann L, Hacke W, Schieber S, Mundiyanapurath S, Purrucker JC, et al. Effect of conscious sedation vs general anesthesia on early neurological improvement among patients with ischemic stroke undergoing endovascular thrombectomy: a randomized clinical trial. JAMA 2016;316:1986–1996.

64. Simonsen CZ, Yoo AJ, Sørensen LH, Juul N, Johnsen SP, Andersen G, et al. Effect of general anesthesia and conscious sedation during endovascular therapy on infarct growth and clinical outcomes in acute ischemic stroke: a randomized clinical trial. JAMA Neurol 2018;75:470–477.

65. Goyal N, Tsivgoulis G, Pandhi A, Chang JJ, Dillard K, Ishfaq MF, et al. Blood pressure levels post mechanical thrombectomy and outcomes in large vessel occlusion strokes. Neurology 2017;89:540–547.

66. Cernik D, Sanak D, Divisova P, Kocher M, Cihlar F, Zapletalova J, et al. Impact of blood pressure levels within first 24 hours after mechanical thrombectomy on clinical outcome in acute ischemic stroke patients. J Neurointerv Surg 2019;11:735–739.

67. Maier IL, Tsogkas I, Behme D, Bähr M, Knauth M, Psychogios MN, et al. High systolic blood pressure after successful endovascular treatment affects early functional outcome in acute ischemic stroke. Cerebrovasc Dis 2018;45:18–25.

68. Cheng H, Xu C, Jin X, Chen Y, Zheng X, Shi F, et al. Association of blood pressure at successful recanalization and parenchymal hemorrhage after mechanical thrombectomy with general anesthesia. Front Neurol 2020;11:582639.

69. Matusevicius M, Cooray C, Bottai M, Mazya M, Tsivgoulis G, Nunes AP, et al. Blood pressure after endovascular thrombectomy: modeling for outcomes based on recanalization status. Stroke 2020;51:519–525.

70. Mistry EA, Sucharew H, Mistry AM, Mehta T, Arora N, Starosciak AK, et al. Blood Pressure after Endovascular Therapy for Ischemic Stroke (BEST): a multicenter prospective cohort study. Stroke 2019;50:3449–3455.

71. Bennett AE, Wilder MJ, McNally JS, Wold JJ, Stoddard GJ, Majersik JJ, et al. Increased blood pressure variability after endovascular thrombectomy for acute stroke is associated with worse clinical outcome. J Neurointerv Surg 2018;10:823–827.

72. Mistry EA, Mehta T, Mistry A, Arora N, Starosciak AK, De Los Rios La Rosa F, et al. Blood pressure variability and neurologic outcome after endovascular thrombectomy: a secondary analysis of the BEST Study. Stroke 2020;51:511–518.

73. Kim TJ, Park HK, Kim JM, Lee JS, Park SH, Jeong HB, et al. Blood pressure variability and hemorrhagic transformation in patients with successful recanalization after endovascular recanalization therapy: a retrospective observational study. Ann Neurol 2019;85:574–581.

74. Anadani M, Matusevicius M, Tsivgoulis G, Peeters A, Nunes AP, Mancuso M, et al. Magnitude of blood pressure change and clinical outcomes after thrombectomy in stroke caused by large artery occlusion. Eur J Neurol 2021;28:1922–1930.

75. Mazighi M, Richard S, Lapergue B, Sibon I, Gory B, Berge J, et al. Safety and efficacy of intensive blood pressure lowering after successful endovascular therapy in acute ischaemic stroke (BP-TARGET): a multicentre, open-label, randomised controlled trial. Lancet Neurol 2021;20:265–274.

76. Anadani M, Arthur AS, Tsivgoulis G, Simpson KN, Alawieh A, Orabi Y, et al. Blood pressure goals and clinical outcomes after successful endovascular therapy: a multicenter study. Ann Neurol 2020;87:830–839.

77. Liu D, Nie X, Pan Y, Yan H, Pu Y, Wei Y, et al. Adverse outcomes associated with higher mean blood pressure and greater blood pressure variability immediately after successful embolectomy in those with acute ischemic stroke, and the influence of pretreatment collateral circulation status. J Am Heart Assoc 2021;10:e019350.

78. Castro P, Ferreira F, Nguyen CK, Payabvash S, Ozan Tan C, Sorond F, et al. Rapid assessment of blood pressure variability and outcome after successful thrombectomy. Stroke 2021;52:e531–e535.

79. Martins AI, Sargento-Freitas J, Silva F, Jesus-Ribeiro J, Correia I, Gomes JP, et al. Recanalization modulates association between blood pressure and functional outcome in acute ischemic stroke. Stroke 2016;47:1571–1576.

80. Mistry EA, Mistry AM, Nakawah MO, Khattar NK, Fortuny EM, Cruz AS, et al. Systolic blood pressure within 24 hours after thrombectomy for acute ischemic stroke correlates with outcome. J Am Heart Assoc 2017;6:e006167.

81. Chang JY, Jeon SB, Lee JH, Kwon OK, Han MK. The relationship between blood pressure variability, recanalization degree, and clinical outcome in large vessel occlusive stroke after an intra-arterial thrombectomy. Cerebrovasc Dis 2018;46:279–286.

82. Martins AI, Sargento-Freitas J, Jesus-Ribeiro J, Correia I, Cardoso L, Gomes JP, et al. Blood pressure variability in acute ischemic stroke: the role of early recanalization. Eur Neurol 2018;80:63–67.

83. Chang JY, Jeon SB, Jung C, Gwak DS, Han MK. Postreperfusion blood pressure variability after endovascular thrombectomy affects outcomes in acute ischemic stroke patients with poor collateral circulation. Front Neurol 2019;10:346.

84. Cho BH, Kim JT, Lee JS, Park MS, Kang KW, Choi KH, et al. Associations of various blood pressure parameters with functional outcomes after endovascular thrombectomy in acute ischaemic stroke. Eur J Neurol 2019;26:1019–1027.

85. Choi KH, Kim JM, Kim JH, Kim JT, Park MS, Choi SM, et al. Optimal blood pressure after reperfusion therapy in patients with acute ischemic stroke. Sci Rep 2019;9:5681.

86. Zhang T, Wang X, Wen C, Zhou F, Gao S, Zhang X, et al. Effect of short-term blood pressure variability on functional outcome after intra-arterial treatment in acute stroke patients with large-vessel occlusion. BMC Neurol 2019;19:228.

87. Anadani M, Arthur AS, Alawieh A, Orabi Y, Alexandrov A, Goyal N, et al. Blood pressure reduction and outcome after endovascular therapy with successful reperfusion: a multicenter study. J Neurointerv Surg 2020;12:932–936.

88. Anadani M, de Havenon A, Yaghi S, Mehta T, Arora N, Starosciak AK, et al. Blood pressure reduction and outcome after endovascular therapy: a secondary analysis of the BEST study. J Neurointerv Surg 2021;13:698–702.

89. Chu HJ, Lin CH, Chen CH, Hwang YT, Lee M, Lee CW, et al. Effect of blood pressure parameters on functional independence in patients with acute ischemic stroke in the first 6 hours after endovascular thrombectomy. J Neurointerv Surg 2020;12:937–941.

90. Carvalho Dias M, Gabriel D, Saraiva M, Campos D, Requena M, García-Tornel Á, et al. Spontaneous systolic blood pressure drop early after mechanical thrombectomy predicts dramatic neurological recovery in ischaemic stroke patients. Eur Stroke J 2020;5:362–369.

91. Ding X, Xu C, Zhong W, Gong X, Zhou Y, Chen Z, et al. Association of maximal systolic blood pressure with poor outcome in patients with hyperattenuated lesions on immediate NCCT after mechanical thrombectomy. J Neurointerv Surg 2020;12:127–131.

92. McCarthy DJ, Ayodele M, Luther E, Sheinberg D, Bryant JP, Elwardany O, et al. Prolonged heightened blood pressure following mechanical thrombectomy for acute stroke is associated with worse outcomes. Neurocrit Care 2020;32:198–205.

93. Gigliotti MJ, Padmanaban V, Richardson A, Simon SD, Church EW, Cockroft KM. Effect of blood pressure management strategies on outcomes in patients with acute ischemic stroke after successful mechanical thrombectomy. World Neurosurg 2021;148:e635–e642.

94. Han B, Sun X, Liu R, Tong X, Jia B, Mo D, et al. Impact of the perioperative blood pressure on clinical outcome after thrombectomy in acute basilar artery occlusion. J Stroke Cerebrovasc Dis 2021;30:105590.

95. Huang X, Guo H, Yuan L, Cai Q, Zhang M, Zhang Y, et al. Blood pressure variability and outcomes after mechanical thrombectomy based on the recanalization and collateral status. Ther Adv Neurol Disord 2021;14:1756286421997383.

96. Malhotra K, Goyal N, Katsanos AH, Filippatou A, Mistry EA, Khatri P, et al. Association of blood pressure with outcomes in acute stroke thrombectomy. Hypertension 2020;75:730–739.

97. De Havenon A, Bennett A, Stoddard GJ, Smith G, Chung L, O’Donnell S, et al. Determinants of the impact of blood pressure variability on neurological outcome after acute ischaemic stroke. Stroke Vasc Neurol 2017;2:1–6.

98. Mattle HP, Kappeler L, Arnold M, Fischer U, Nedeltchev K, Remonda L, et al. Blood pressure and vessel recanalization in the first hours after ischemic stroke. Stroke 2005;36:264–268.

99. Brott T, Lu M, Kothari R, Fagan SC, Frankel M, Grotta JC, et al. Hypertension and its treatment in the NINDS rt-PA stroke trial. Stroke 1998;29:1504–1509.

100. Goyal M, Demchuk AM, Menon BK, Eesa M, Rempel JL, Thornton J, et al. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med 2015;372:1019–1030.

101. Jovin TG, Saver JL, Ribo M, Pereira V, Furlan A, Bonafe A, et al. Diffusion-weighted imaging or computerized tomography perfusion assessment with clinical mismatch in the triage of wake up and late presenting strokes undergoing neurointervention with Trevo (DAWN) trial methods. Int J Stroke 2017;12:641–652.

102. Parati G, Ochoa JE, Lombardi C, Bilo G. Assessment and management of blood-pressure variability. Nat Rev Cardiol 2013;10:143–155.

103. Kim BJ, Cho YJ, Hong KS, Lee J, Kim JT, Choi KH, et al. Trajectory groups of 24-hour systolic blood pressure after acute ischemic stroke and recurrent vascular events. Stroke 2018;49:1836–1842.

104. Nagin DS, Odgers CL. Group-based trajectory modeling in clinical research. Annu Rev Clin Psychol 2010;6:109–138.

105. Müller M, Österreich M, Lakatos L, Hessling AV. Cerebral macro- and microcirculatory blood flow dynamics in successfully treated chronic hypertensive patients with and without white mater lesions. Sci Rep 2020;10:9213.

106. Anadani M, de Havenon A, Mistry E, Anderson CS. Blood pressure management after endovascular therapy: an ongoing debate. Stroke 2021;52:e263–e265.

Article information Continued

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Study	Year	Study subjects	Major BP indices	Major findings
Nogueira et al. [36]	2009	305 LVO patients included in the MERCI and multi-MERCI trials	BP on admission	Higher SBP on admission associated with unfavorable outcomes but an independent predictor of successful recanalization
Maier et al. [38]	2017	1,042 LVO patients with EVT from ETIS registry	BP on admission	Admission SBP showed J- or U-shaped association with mortality, with the inflection point at SBP 157 mm Hg
Mulder et al. [37]	2017	500 LVO patients included in the MR CLEAN trial	BP at baseline, before EVT (for EVT group) or stroke unit admission (for the no-EVT group)	Baseline SBP showed U-shape association with functional outcome
High SBP associated with mortality and symptomatic hemorrhage
No interaction between SBP level and EVT
Goyal et al. [41]	2017	116 LVO patients with EVT	SBP on admission	Admission SBP correlated with final infarct volume
Higher admission SBP associated with mRS 0–2
Schonenberger et al. [40]^*	2018	150 EVT cases randomized to GA or CS from the SIESTA trial	BP measurements were divided into 4 phases: pre-EVT, pre-recanalization, post- recanalization, and post-EVT	No association between the difference in SBP, DBP, and MAP from baseline to the different phases of intervention with 24-hour NIHSS
No association of BP drop with a change in mRS
Anadani et al. [42]	2020	381 EVT cases from the ASTER trial	Baseline BP prior to randomization	No association between admission BP with mRS or successful revascularization
van den Berg et al. [39]	2020	3180 EVT patients from the MR CLEAN registry	BP on admission	J-shaped association with mRS and mortality with inflection points at 150 and 81 mm Hg
Higher SBP associated with poor mRS and mortality

Study	Year	Study subjects	Major BP indices	Major findings
Davis et al. [43]	2012	96 EVT cases (48 GA and 48 LA)	SBP, DBP, and MAP (minimum and maximum values for each) in LA and GA groups	Higher rates of mRS 0–2 in LA groups; lower SBP levels in GA group
Hendén et al. [53]	2015	108 EVT cases	Fall in MAP of >40% compared to the baseline under GA	Fall in MAP of >40% from baseline associated with poor neurological recovery
John et al. [54]	2015	147 EVT during 2008–2012	Levels of BP during the EVT procedure under GA	Lower maximum intraprocedural SBP associated with mRS 0–2
Jagani et al. [44]	2016	99 EVT with CS or GA	Maximum or minimum values of SBP, DBP, and MAP	GA associated with lower BP levels and poor outcome
Whalin et al. [55]	2017	255 Anterior circulation occlusions with mTICI ≥2b with monitored anesthesia care	MAP level during the procedure with monitored anesthesia care	10% MAP drop associated with poor functional outcome
Athiraman et al. [56]	2018	88 EVTs under GA	Episodes or durations of SBP lower than specific thresholds	Lower SBP levels associated with poor outcome
Pikija et al. [46]	2018	164 EVT cases under GA	In-procedure SBP and MAP excursions to >120%/80% of the reference value and the reference BP/weighted in-procedure mean BP	High in-procedure SBP/MAP excursion to >120% associated with lower infarct volume and mRS 0–2
Higher in-procedure mean SBP/MAP associated with lower rates of hemorrhage
Rasmussen et al. [45]	2018	128 EVT patients randomized to GA or CS from the GOLIATH trial	Levels and durations of SBP or MAP lower than specific thresholds	Higher MAP or SBP levels in CS group
No significant difference in the association between BP parameters and mRS
Schonenberger et al. [40]^*	2018	150 EVT cases randomized to GA or CS from the SIESTA trial	BP measurements were divided into 4 phases: pre-EVT, pre-recanalization, post-recanalization, and post-EVT	No association between the difference in SBP, DBP, and MAP from baseline to the different phases of intervention with 24 hours NIHSS
No association of BP drop (magnitude of changes) with a change in mRS
Treurniet et al. [57]	2018	60 EVT under GA in the MR CLEAN trial	Levels and changes of SBP, DBP, and MAP during the procedure	Greater MAP reduction associated with worse functional outcome
Petersen et al. [47]	2019	390 EVTs from two comprehensive stroke centers	Intraprocedural MAP, delta MAP (baseline MAP–lowest MAP during EVT procedures before recanalization)	MAP reduction noted in 87% of cases during EVT Delta-MAP associated with infarct growth and
infarct volume; Delta-MAP correlated with higher mRS at discharge
Pikija et al. [58]	2019	39 BAO with EVT	BP levels and variability indices; difference of peak and trough values, SD, CV, ARV; reference SBP calculated as a median of the first five procedural measurements	Shorter procedural duration of SBP <140 associated with successful recanalization
Higher SBP and longer duration of SBP over 180 mm Hg associated with hemorrhage
Fandler-Hofler et al. [59]	2020	115 Anterior circulation occlusion patients with EVT under GA	Peri-interventional BP levels and reduction	Single BP drop associated with poor outcome
Maïer et al. [51]	2020	381 Patients from the ASTER trial	Dynamic BP parameter, CV; steady BP parameter, hypotension time of SBP <140 or MAP <90	BP variability parameter associated with poor outcomes regardless of collateral status
Hypotension time associated with poor outcomes only in patients with poor collaterals
Petersen et al. [52]	2020	90 EVTs for anterior circulation occlusions	Optimal ranges of MAP based on an autoregulatory index calculated by a real-time NIRS in response to changes in MAP	Percent time of MAP greater than the upper limit of the optimal range associated with worse 90- day outcomes and trends in hemorrhage
Rasmussen et al. [49]	2020	368 EVT patient’s data from SIESTA, ANSTROKE, GOLIATH trials (CS vs. GA)	Levels and durations of MAP greater or less than thresholds	Cumulative hypo- (MABP <70 mm Hg for >10 minutes) and hypertension (MABP >90 mm Hg for >45 minutes) associated with poor functional outcomes
Valent et al. [48]	2020	371 EVT cases under GA or CS	Baseline BP; BP measured in the interventional suite immediately before the induction	The time below 90% of the reference value associated with mRS ≥3
Duration of arterial hypotension (below the baseline BP)
Samuels et al. [50]	2021	440 EVT patients from the MR CLEAN registry, under CS or LA	Changes and duration of MAP levels	Lower MAP levels in CS; worse outcome in CS
Xu et al. [60]	2021	131 EVT patients after LVO under GA	Delta MAP; MAP every 5 minutes–baseline MAP	Longer duration delta MAP associated with poor outcome, but only documented in mild reduction group
Cumulated time and the longest continuous episode of delta MAP <10, 15, 20, 25, and 30 mm Hg
Chen et al. [61]	2021	139 EVT cases with successful recanalization	Procedural BPs categorized into baseline, pre-recanalization, postrecanalization, and post-intervention	High pre-recanalization BPs associated with poor outcomes; protocol-based BP lowering during EVT not associated with outcomes

Table 3.

Post-procedural BP and the recanalization treatment outcomes

Study	Year	Study subjects	Major BP indices	Major findings
Martins et al. [79]	2016	674 IVT or EVT cases	BP every 2 hours for 24 hours after admission	SBP showed J-shape in non-recanalized group but linear association in recanalized group
Mistry et al. [80]	2017	228 EVT from three hospitals	BP (max, min, and average) in the first 24 hours after EVT	High peak SBP correlated with worse functional outcome and hemorrhagic complications
Goyal et al. [65]	2017	217 LVO with EVT with hourly BP	BP goals post EVT; permissive hypertension (<220 or 185), moderate BP control (<160), intensive BP control (<140)	Higher SBPmax associated with mortality
Goyal et al. [65]	2017	217 LVO with EVT with hourly BP		Intensive BP target (<140/90 mm Hg) associated with higher rates of mRS 0–2
Bennett et al. [71]	2018	182 LVO patients with EVT	Post-procedural BP variability indices; SD, CV, and SV	High BPV associated with high mRS
Chang et al. [81]	2018	303 LVO patients with EVT	Post-procedural BP variability indices; SD, CV, and VIM	High BPV associated with poor functional recovery and low successful recanalization
Maier et al. [67]	2018	168 Anterior circulation occlusions with successful recanalization after EVT	Mean, max, and peak SBP for the first 24 hours after successful EVT	High mean SBP and maximum SBP associated with unfavorable outcome
Martins et al. [82]	2018	674 IVT or EVT	Standard deviations of SBP and DBP during the first 24 hours after stroke	A differential effect from SD of SBP on mRS by recanalization status; significant only in non-recanalized patients
Schonenberger et al. [40]^*	2018	150 EVT cases randomized to GA or CS from the SIESTA trial	BP measurements were divided into 4 phases: pre-EVT, pre-recanalization, post-recanalization, and post-EVT	No association between the difference in SBP, DBP, and MAP from baseline to the different phases of intervention and NIHSS change after 24 hours
Schonenberger et al. [40]^*	2018	150 EVT cases randomized to GA or CS from the SIESTA trial		No association of BP drops with a change in mRS
Cernik et al. [66]	2019	690 EVT patients	Levels of SBP and DBP	Low BP levels associated with better functional recovery or recanalization
Chang et al. [83]	2019	90 EVT with mTICI ≥2b	BP variability indices	BP variability associated with poor mRS only in patients with poor collaterals at baseline
Cho et al. [84]	2019	378 EVTs	Levels and variability indices during the first 24 hours after admission	Higher mean SBP and SV of SBP associated with poor mRS; the effect of SV modified by recanalization status
Choi et al. [85]	2019	1,540 AIS patients after IVT or EVT	BP ≤130/80 mm Hg	Lower BP levels associated with mRS 0–2
Kim et al. [73]	2019	211 EVT with mTICI ≥2b	Levels, excursions, variability indices, and time rate of BP variation	BP variability indices associated with higher rates of SICH
Mistry et al. [70]	2019	485 Consecutive EVT patients from 12 centers	All SBP values within 24 hours post EVT	Peak SBP <158 mm Hg associated with good functional outcome
				Overall, SBP showed a U-shape association with outcome
				Higher BP levels after EVT associated with poor outcome
Zhang et al. [86]	2019	72 LVOs with EVT	Post-procedural BP variability indices; SD, CV, and SV	Higher SV of SBP correlated with mRS at 3 months
Anadani et al. [87]	2020	1,361 EVT cases from an international multicenter study	SBP reduction in the first 24 hours after EVT	SBP reduction associated with a good outcome only in patients with complete reperfusion (mTICI, 3)
Anadani et al. [88]	2020	433 EVT cases from the BEST study [70]	SBP reduction, the absolute difference between admission SBP and mean SBP in the first 24 hours	No association between SBP with poor outcome or death
Anadani et al. [76]	2020	1,019 Anterior circulation occlusion patients with EVT from eight comprehensive stroke centers	Post-EVT BP target, <140, <160, and <180	Lower SBP goal (<140 or <160, compared to <180) associated with good outcome
Anadani et al. [76]	2020		Post-EVT BP target, <140, <160, and <180	However, mean achieved SBP levels tended to overlap
Cheng et al. [68]	2020	124 Anterior circulation occlusion patients with EVT	Two BP measurements immediately after successful recanalization	Higher BP associated with PH2 hemorrhagic transformation
Chu et al. [89]	2019	166 EVT patients	Hourly BP after EVT, by 1–6, 7–12, 13–18, and 19–24 hours	Lower mean, max, SD of SBP, and DBP associated with functional independence, in <6 hours
Dias et al. [90]	2020	458 EVT cases	Median SBP within the first hour after EVT	Lower median SBP associated with NIHSS reduction by 8 or ≤2 at 24 hours
Ding et al. [91]	2020	262 EVT cases	Maximum SBP and DBP for 24 hours after the EVT	Max SBP associated with poor mRS and parenchymal hemorrhage (hyper attenuated lesion on immediate CT, cannot distinguish from contrast staining)
Matusevicius et al. [69]	2020	3,631 EVT cases from the SITS-ISTR	Mean 24-hour SBP after EVT	Higher SBP associated with poor functional recovery in successful recanalization patients and with SICH in all recanalization
McCarthy et al. [92]	2020	212 EVT patients	Daily peak SBP and DBP	Higher peak 24-hour SBP associated with SICH and poor outcome
McCarthy et al. [92]	2020	212 EVT patients	Daily peak SBP and DBP	Higher peak SBP at day 2 and day 3 associated with poor outcome
Mistry et al. [72]	2020	443 EVT cases from the BEST study [70]	Systolic BPV (SD, CV, ARV, SV, and rSD) during 24 hours after EVT	Higher BP variability associated with poor outcome and mortality
Anadani et al. [74]	2021	5,835 EVT patients from the SITS-ISTR registry	Delta SBP (SBP–baseline SBP) 0–2/2–4/4–12/12–24 hours	SBP elevation after EVT associated with poor functional outcome
Gigliotti et al. [93]	2021	117 EVT cases	SBP for 24 hours after EVT	SBP ≥180 associated with poor function at discharge but not at 3 months
Gigliotti et al. [93]	2021	117 EVT cases	SBP for 24 hours after EVT	SBP ≥160 associated with malignant cerebral edema with lower symptomatic hemorrhage
Han et al. [94]	2021	187 BAO with EVT	Levels of SBP, MAP, and DBP	Maximum SBP and maximum MAP associated with mortality
Huang et al. [95]	2021	502 Anterior circulation LVO patients with EVT	Levels and variability indices of SBP and DBP	High BP variability associated with poor functional recovery and hemorrhagic complications, differentiated by recanalization status, not by baseline collaterals
Liu et al. [77]	2021	596 LVO patients with EVT (GA in 37%)	BP for 24 hours after EVT	Higher mean SBP levels, mean SBP >140, and SD of SBP associated with the unfavorable outcome only in poor collaterals subgroup
Mazighi et al. [75]	2021	324 LVO patients with EVT (BP-TARGET trial)	Randomized to intensive SBP target (100–129) vs. standard SBP target (130–185) for 24 hours	No difference in the primary outcome (any hemorrhage or hypotensive event)
Castro et al. [78]	2021	146 Anterior circulation LVO with successful recanalization	Spectral analysis of 5-minute recordings of beat-to-beat BP	High frequency BP variability associated with cerebral edema and unfavorable functional outcomes

BP, blood pressure; IVT, intravenous thrombolysis; EVT, endovascular treatment; SBP, systolic blood pressure; LVO, large vessel occlusion; mRS, modified Rankin Scale; SD, standard deviation; CV, coefficient of variation; SV, successive variation; BPV, BP variability; VIM, variation independent of the mean; GA, general anesthesia; CS, conscious sedation; SIESTA, Sedation vs. Intubation for Endovascular Stroke Treatment trial; DBP, diastolic blood pressure; MAP, mean arterial pressure; NIHSS, National Institutes of Health Stroke Scale; mTICI, modified treatment in cerebral ischemia; AIS, acute ischemic stroke; SICH, symptomatic intracranial hemorrhage; BEST, Blood Pressure after Endovascular Therapy for Ischemic Stroke study; CT, computed tomography; PH2, parenchymal hemorrhage type 2; SITS-ISTR, Safe Implementation of Thrombolysis in Stroke International Stroke Thrombolysis Registry; ARV, average real variation; rSD, residual standard deviation; BAO, basilar artery occlusion; BP-TARGET, Blood Pressure target in Acute Stroke to Reduce Hemorrhage after Endovascular Therapy trial.

This article covers all peri-EVT periods.